HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs.

Abstract
Gaucher disease is caused by an inherited deficiency of glucocerebrosidase that manifests with storage of glycolipids in lysosomes, particularly in macrophages. Available cell lines modeling Gaucher disease do not demonstrate lysosomal storage of glycolipids; therefore, we set out to develop two macrophage models of Gaucher disease that exhibit appropriate substrate accumulation. We used these cellular models both to investigate altered macrophage biology in Gaucher disease and to evaluate candidate drugs for its treatment. We generated and characterized monocyte-derived macrophages from 20 patients carrying different Gaucher disease mutations. In addition, we created induced pluripotent stem cell (iPSC)-derived macrophages from five fibroblast lines taken from patients with type 1 or type 2 Gaucher disease. Macrophages derived from patient monocytes or iPSCs showed reduced glucocerebrosidase activity and increased storage of glucocerebroside and glucosylsphingosine in lysosomes. These macrophages showed efficient phagocytosis of bacteria but reduced production of intracellular reactive oxygen species and impaired chemotaxis. The disease phenotype was reversed with a noninhibitory small-molecule chaperone drug that enhanced glucocerebrosidase activity in the macrophages, reduced glycolipid storage, and normalized chemotaxis and production of reactive oxygen species. Macrophages differentiated from patient monocytes or patient-derived iPSCs provide cellular models that can be used to investigate disease pathogenesis and facilitate drug development.
AuthorsElma Aflaki, Barbara K Stubblefield, Emerson Maniwang, Grisel Lopez, Nima Moaven, Ehud Goldin, Juan Marugan, Samarjit Patnaik, Amalia Dutra, Noel Southall, Wei Zheng, Nahid Tayebi, Ellen Sidransky
JournalScience translational medicine (Sci Transl Med) Vol. 6 Issue 240 Pg. 240ra73 (Jun 11 2014) ISSN: 1946-6242 [Electronic] United States
PMID24920659 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
CopyrightCopyright © 2014, American Association for the Advancement of Science.
Chemical References
  • Glucosylceramides
  • Psychosine
  • sphingosyl beta-glucoside
  • Glucosylceramidase
Topics
  • Cells, Cultured
  • Gaucher Disease (metabolism, pathology)
  • Glucosylceramidase (metabolism)
  • Glucosylceramides (metabolism)
  • Humans
  • Induced Pluripotent Stem Cells (cytology)
  • Lysosomes (metabolism)
  • Macrophages (cytology, metabolism)
  • Monocytes (metabolism)
  • Psychosine (analogs & derivatives, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: